Convertible Note Payable	3 Months Ended
Mar. 31, 2013
Convertible Note Payable [Abstract]
Convertible Note Payable	(6) Convertible Note Payable On October 9, 2012, the Company signed a $27,500 convertible promissory note with a third party. The note bears interest at 8% per annum and is due on June 25, 2013. The note has conversion rights that allow the holder of the note to convert after 180 days all or any part of the remaining principal balance into the Company’s common stock at a price equal to 51% of the average of the lowest three trading prices for the Common Stock during the most recent ten day period. On February 14, 2013, the Company signed a $37,500 convertible promissory note with a third party. The note bears interest at 8% per annum and is due on November 14, 2013. The note has conversion rights that allow the holder of the note to convert after 180 days all or any part of the remaining principal balance into the Company’s common stock at a price equal to 51% of the average of the lowest three trading prices for the Common Stock during the most recent ten day period. In accordance with ASC 470, the Company has analyzed the beneficial nature of the conversion terms and determined that a beneficial conversion feature (BCF) exists. The Company calculated the value of the BCF using the intrinsic method as stipulated in ASC 470. The BCF has been recorded as a discount to the notes payable and to Additional Paid-in Capital. As of March 31, 2013, the balance of convertible notes payable was $26,136 net of unamortized discounts of $38,864. For the three months ended March 31, 2013 the Company has recognized $1,289 in interest expense related to these and has amortized $32,321 of the beneficial conversion features which has been recorded as interest expense.

Convertible Note Payable

3 Months Ended

Mar. 31, 2013

(6) Convertible Note Payable

On October 9, 2012, the Company signed a $27,500 convertible promissory note with a third party. The note bears interest at 8% per annum and is due on June 25, 2013. The note has conversion rights that allow the holder of the note to convert after 180 days all or any part of the remaining principal balance into the Company’s common stock at a price equal to 51% of the average of the lowest three trading prices for the Common Stock during the most recent ten day period.

On February 14, 2013, the Company signed a $37,500 convertible promissory note with a third party. The note bears interest at 8% per annum and is due on November 14, 2013. The note has conversion rights that allow the holder of the note to convert after 180 days all or any part of the remaining principal balance into the Company’s common stock at a price equal to 51% of the average of the lowest three trading prices for the Common Stock during the most recent ten day period.

In accordance with ASC 470, the Company has analyzed the beneficial nature of the conversion terms and determined that a beneficial conversion feature (BCF) exists. The Company calculated the value of the BCF using the intrinsic method as stipulated in ASC 470. The BCF has been recorded as a discount to the notes payable and to Additional Paid-in Capital.

As of March 31, 2013, the balance of convertible notes payable was $26,136 net of unamortized discounts of $38,864.

For the three months ended March 31, 2013 the Company has recognized $1,289 in interest expense related to these and has amortized $32,321 of the beneficial conversion features which has been recorded as interest expense.

MEDISAFE 1 TECHNOLOGIES CORP 10-Q